Company: ABBV
Filing Date: 2025-02-14
Form Type: S-3ASR
Source: 0001104659-25-014191
Chunk: 14

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: S-3ASR
Chunk 14
---
 of directors or officers for monetary damages for actions taken as a director or officer of the registrant, or for serving at the registrant’s request as a director or officer or another position at another corporation or enterprise, as the case may be. The registrant’s amended and restated certificate of incorporation and third amended and restated by-laws also provide that the registrant must indemnify and advance reasonable expenses to its directors and officers, subject to its receipt of an undertaking from the indemnified party as may be required under the DGCL. The registrant’s third amended and restated by-laws expressly authorize the registrant to carry directors’ and officers’ insurance to protect the registrant, its directors, officers and certain employees from some liabilities.

II-1

TABLE OF CONTENTS

The foregoing is only a general summary of certain aspects of Delaware law and the registrant’s amended and restated certificate of incorporation and third amended and restated by-laws dealing with indemnification of directors and officers and does not purport to be complete. It is qualified in its entirety by reference to the detailed provisions of those sections of the DGCL referenced above and the amended and restated certificate of incorporation and third amended and restated by-laws of the registrant. Item 16. Exhibits. The following exhibits are included herein or incorporated herein by reference:

| ​ 
 ​ 
 ​ | ExhibitNo. 
       1.1* 
        4.1 | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | Description                                                                                                                                                                                                                                                            
 Form of Underwriting Agreement                                                                                                                                                                                                                                         
 Indenture, dated as of November 8, 2012, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit 4.1 of Amendment No. 5 to the Company’s Registration Statement on Form 10 filed on November 16, 2012) | ​ 
 ​ 
 ​ |
|:--|-----------:|:--|:--|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--|
| ​ |        4.2 | ​ | ​ | Form of Debt Security (included in Exhibit 4.1)                                                                                                                                                                                                                        | ​ |
| ​ |      5.1** | ​ | ​ | Opinion of Kirkland & Ellis LLP                                                                                                                                                                                                                                        | ​ |
| ​ |     23.1** | ​ | ​ | Consent of Ernst & Young LLP                                                                                                                                                                                                                                           | ​ |
| ​